1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
C.Q. Pharmaceutical Holding Co., Ltd.

C.Q. Pharmaceutical Holding Co., Ltd.

000950.SZ
C.Q. Pharmaceutical Holding Co., Ltd.CN flagShenzhen Stock Exchange
5.39
CNY
+0.07
- -
9.31BMarket Cap
C.Q. Pharmaceutical Holding Co., Ltd.
000950.SZ
(Shenzhen Stock Exchange)

Recent

price

5.39

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3.45
4.27
5.48
6.79
4.93
5.53
13.28
13.33
14.94
19.76
26.08
36.07
39.18
45.18
45.55
46.9
45.82
Revenue per Share
0.22
0.15
0.2
0.02
-0.6
-0.61
0.15
0.64
0.4
0.46
0.51
0.58
0.55
0.36
0.16
0.22
0.18
Basic EPS, GAAP
-0.83
-0.52
-0.12
-1.92
-0.98
0.09
-0.24
-0.73
-1.16
-0.36
0.15
-0.14
0.01
0.15
-0.25
0.26
-0.16
Free Cash Flow per Basic Share
0.12
0.24
0.31
0.25
0.38
0.4
0.16
0.07
0.07
0.16
0.38
0.71
0.54
0.75
0.63
0.5
0.57
Dividend per Share
2.01
2.03
2.06
2.48
1.47
0.86
1.05
2.35
2.79
3.27
3.68
4.22
4.71
4.98
4.96
5.15
5.03
Book Value per Share
3.8
3.98
3.86
4.47
2.68
2.13
3.16
3.98
4.22
4.6
5.02
5.77
6.29
7.83
8.27
8.39
8.23
Tangible Book Value per Share
602
606
607
506
602
602
1,763
1,729
1,727
1,713
1,734
1,734
1,731
1,735
1,769
1,758
1,789
Basic Weighted Avg Shares
2,078
2,589
3,323
3,437
2,969
3,326
23,416
23,045
25,803
33,844
45,220
62,521
67,829
78,397
80,562
82,447
81,971
Sales/Revenue/Turnover
6.98
6.21
5.79
0.8
-8.88
-5.72
0.76
3.32
3.66
4.14
4.21
4
3.49
3.08
2.29
2.32
2.36
Operating Margin (%)
120
88
156
222
229
367
450
293
66
78
125
313
404
397
466
476
- -
Depreciation Expense
132
91
121
10
-361
-367
264
1,106
691
788
884
1,005
952
625
283
387
327
Net Income, GAAP
14.16
17.06
13.45
27.89
- -
- -
34.9
7
12.06
15.51
16.52
18.33
21.02
24.43
27.93
22.41
22.57
Effective Tax Rate (%)
6.37
3.51
3.65
0.29
-12.18
-11.04
1.13
4.8
2.68
2.33
1.96
1.61
1.4
0.8
0.35
0.47
0.4
Profit Margin (%)
709
788
1,378
493
-188
-610
1,915
4,589
5,705
5,152
7,816
9,613
8,034
11,674
13,356
10,211
12,310
Working Capital
1,315
1,341
2,116
2,752
3,138
2,575
1,316
39
978
1,220
4,234
5,634
3,327
4,613
5,482
2,710
4,420
LT Debt
2,385
2,513
2,432
2,440
2,075
1,713
6,227
7,252
8,232
8,862
10,481
11,767
12,710
15,465
16,463
16,554
16,572
Total Equity
3.41
3.48
3.86
0.38
- -
- -
1.47
7.72
8.08
8.46
7.64
7.37
5.85
5.27
3.61
3.78
3.99
Return on Invested Capital (%)
6.94
5.96
5.65
1.95
- -
- -
7.44
22.28
10.41
8.7
6.44
6.35
5.45
4.68
2.79
2.26
2.61
Return on Capital (%)
12.54
7.46
9.78
0.81
-33.79
-52.27
22.32
37.38
15.55
15.14
14.76
14.67
12.31
7.44
3.25
4.34
3.67
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
17,966
18,324
19,270
LT Borrowings
5,223
4,619
4,109
LT Finance Leases
259
289
311
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,728
1,728
1,728
Market Capitalization
9,232
9,071
8,927

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
57,420
59,203
58,745
Cash, Cash Equivalents & STI
9,392
6,974
6,295
Accounts Receivable, Net
32,948
36,299
36,847
Inventories
9,977
9,900
10,293
Total Current Liabilities
44,064
46,382
46,435
Payables & Accruals
- -
- -
- -
ST Debt
17,966
18,324
19,270
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
36.83%
9.79%
0.55%
Free Cash Flow
-20.57%
123.11%
-204.09%
Net Income, GAAP
9.11%
-8.81%
36.65%
Sales/Revenue/Turnover
74.65%
13.49%
2.34%
Total Cash Common Dividend
28.69%
12.87%
-22.01%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
19,624
20,155
19,913
20,869
80,562
2025
20,612
20,576
20,236
- -
82,447
2026
20,432
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
- -
- -
- -
0.16
2025
0.07
- -
- -
- -
0.22
2026
0.1
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.15
- -
- -
- -
0.63
2025
0.13
- -
- -
- -
0.5
2026
0.12
- -
- -
- -
- -
Similar Companies
Sangani Hospital Ltd. (SANGANI.NS)
biote Corp. (BTMD)
Middle East Healthcare Company (4009.SR)
Selectis Health, Inc. (GBCS)
Etao International Co., Ltd. (ETAOF)
Avem Health Partners, Inc. (FPCG)
Business
C.Q. Pharmaceutical Holding Co., Ltd. C.Q. Pharmaceutical Holding Co., Ltd. (000950.SZ), a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company, principally engages in the wholesale and retail distribution of pharmaceutical products throughout China; it conducts research, development, production, and investment in the pharmaceutical industry, including medical devices; and provides warehousing, logistics, and supply chain value-added services. The company offers a comprehensive range of medicines, medical devices, Chinese herbal medicines, health care products, and Chinese medicine tablets; operates hospital sales, commercial wholesale, retail chains, and terminal distribution networks; and delivers auxiliary medical services such as chronic disease management, electronic prescription circulation, outpatient pharmacy management, remote diagnosis and treatment, as well as medical care products for elderly care and rehabilitation while managing medical institutions. Founded in 1999 and headquartered in Chongqing, China, with approximately 13,820 employees, C.Q. Pharmaceutical Holding Co., Ltd. serves the full pharmaceutical industry chain as a fixed-point reserve unit for drugs and medical equipment; in 2025, it joined China General Technology (Group) Holdings Co., Ltd., transitioning from a local state-owned enterprise to a central enterprise in Chongqing, and completed the acquisition of a 10% stake in Chongqing Chemical and Pharmaceutical Holdings Group Finance Co.